Search for: "NOVARTIS PHARMA V TEVA PHARMA" Results 1 - 20 of 139
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2018, 11:13 am
In its ruling,  the Court ordered Teva to pay Novartis more than €13,000,000 as an advance on damages (€5,846,628 to Novartis Pharma AG, the Swiss company which owns the patent, and €7,308,285 to Novartis Pharma SAS, the French licensee). [read post]
30 Aug 2011, 5:18 am by Lawrence B. Ebert
Teva, the world's largest generic drug company, won a court battle in SDNY in its role as a proprietary drug company making Copaxone, against Novartis AG's Sandoz unit, Momenta Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd. [read post]
28 Sep 2007, 8:51 am
Late today, the Court of Appeals for the Federal Circuit denied Novartis's emergency motion to enjoin Teva from selling generic Famvir (Teva press release; Globes article). [read post]
15 May 2011, 8:55 pm by Patent Docs
Elan Corp. et al. v. [read post]
17 Aug 2009, 8:01 am
For example, Teva has challenged and prevailed over Novartis, concerning the right to manufacture a generic copy of Lotrel, even though Novartis’ patent is valid until 2017. [read post]
17 Aug 2009, 8:01 am
For example, Teva has challenged and prevailed over Novartis, concerning the right to manufacture a generic copy of Lotrel, even though Novartis’ patent is valid until 2017. [read post]
15 Feb 2011, 5:26 pm by Marie Louise
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs)… [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
29 Jun 2011, 3:34 am by Marie Louise
(Patent Docs) Deferacirox – India: Cipla wins pre grant opposition (593/CHENP/2005): Novartis v. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360) Fentora… [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
31 Oct 2008, 11:53 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
1 Oct 2007, 8:51 am
Late last Friday the Court of Appeals for the Federal Circuit denied Novartis's emergency motion to enjoin Teva from selling generic Famvir (Teva press release; Globes article). [read post]
19 Apr 2011, 5:04 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
31 Aug 2011, 2:30 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
5 Dec 2008, 1:00 pm
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]